ArticleCell cycle (Georgetown, Tex.)2022

Apurinic/apyrimidinic endonuclease triggered doxorubicin-releasing DNA nanoprism for target therapy.

Meng Liang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.